We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$3.34B
AUM Growth
+$49M
Cap. Flow
+$127M
Cap. Flow %
3.8%
Top 10 Hldgs %
58.49%
Holding
82
New
2
Increased
32
Reduced
32
Closed
3

Top Buys

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$224M
2
TCOM icon
Trip.com Group
TCOM
+$41.9M
3
BAP icon
Credicorp
BAP
+$36.6M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$20M
5
BABA icon
Alibaba
BABA
+$18.6M

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$124M
2
ABEV icon
Ambev
ABEV
+$59M
3
EXC icon
Exelon
EXC
+$26.4M
4
ORCL icon
Oracle
ORCL
+$21.4M
5
KR icon
Kroger
KR
+$16.8M

Sector Composition

Rank Sector Weight
1 Financials 34.68%
2 Communication Services 16.9%
3 Technology 11.43%
4 Consumer Discretionary 11.18%
5 Healthcare 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
51
Elevance Health
ELV
$81.9B
$3.77M 0.11%
10,100
+2,000
+25% +$760K
JWN
52
DELISTED
Nordstrom
JWN
$3.65M 0.11%
138,092
-6,373
-4% -$203K
GILD icon
53
Gilead Sciences
GILD
$160B
$3.14M 0.09%
45,000
-45,000
-50% -$3.16M
AERI
54
DELISTED
Aerie Pharmaceuticals
AERI
$3.08M 0.09%
270,000
+30,000
+13% +$439K
ITCI
55
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.98M 0.09%
80,000
+20,000
+33% +$695K
LNTH icon
56
Lantheus
LNTH
$6.64B
$2.83M 0.08%
110,000
-20,000
-15% -$522K
BKD icon
57
Brookdale Senior Living
BKD
$3.48B
$2.79M 0.08%
442,452
– –
JAZZ icon
58
Jazz Pharmaceuticals
JAZZ
$15.7B
$2.73M 0.08%
21,000
+6,000
+40% +$907K
PRQR icon
59
ProQR Therapeutics
PRQR
$241M
$2.69M 0.08%
321,360
– –
XENE icon
60
Xenon Pharmaceuticals
XENE
$5.97B
$2.6M 0.08%
170,000
– –
ICPT
61
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.51M 0.08%
168,800
– –
NVST icon
62
Envista
NVST
$4.47B
$2.09M 0.06%
50,000
– –
KURA icon
63
Kura Oncology
KURA
$806M
$2.06M 0.06%
110,000
+20,000
+22% +$377K
AXGN icon
64
Axogen
AXGN
$2.46B
$2.05M 0.06%
130,000
+20,000
+18% +$359K
SGMO
65
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.95M 0.06%
216,500
– –
ATRA icon
66
Atara Biotherapeutics
ATRA
$76.2M
$1.79M 0.05%
4,000
+400
+11% +$143K
FATE icon
67
Fate Therapeutics
FATE
$291M
$1.6M 0.05%
27,000
-3,000
-10% -$235K
MGNX icon
68
MacroGenics
MGNX
$235M
$1.47M 0.04%
70,000
– –
CABA icon
69
Cabaletta Bio
CABA
$435M
$1.46M 0.04%
120,000
-10,000
-8% -$92.2K
AGTC
70
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.13M 0.03%
376,900
– –
JD icon
71
JD.com
JD
$44.6B
$1.09M 0.03%
15,153
-95
-0.6% -$7K
TS icon
72
Tenaris
TS
$28.7B
$923K 0.03%
43,734
-271
-0.6% -$5.5K
KZR
73
DELISTED
Kezar Life Sciences
KZR
$864K 0.03%
10,000
– –
INFY icon
74
Infosys
INFY
$49.7B
$851K 0.03%
38,267
-6,827
-15% -$154K
DCTH icon
75
Delcath Systems
DCTH
$445M
$835K 0.03%
80,000
– –
1 2
3
4

Similar funds

MC
Maplelane Capital New York $2.79B AUM 52.02% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $2.8B AUM 79.27% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
NSLI
Nan Shan Life Insurance Taipei City, Taiwan $2.76B AUM 6.75% 1-Year Est. Return

Altrinsic Global Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Altrinsic Global Advisors held 82 positions worth $3.34B, up 1.5% from $3.29B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Altrinsic Global Advisors deployed $127M of net new capital in Q3 2021, opening 2 new positions and adding to 32 existing holdings. Its largest new stake was Willis Towers Watson: 1,004,553 shares worth $234M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 29% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Aon, an estimated $124M trimmed.

  • Altrinsic Global Advisors's largest Q3 2021 buy was Willis Towers Watson: 1,004,553 shares worth $234M.
  • Altrinsic Global Advisors added most to Trip.com Group in Q3 2021, an estimated $41.9M increase.
  • Altrinsic Global Advisors's biggest Q3 2021 reduction was Aon, cutting an estimated $124M.
  • Altrinsic Global Advisors fully exited Ambev in Q3 2021, selling an estimated $59M.
  • Altrinsic Global Advisors's ten largest holdings make up 58% of its $3.34B portfolio in Q3 2021.
  • Altrinsic Global Advisors opened 2 new positions and closed 3 in Q3 2021.
  • Altrinsic Global Advisors's portfolio value rose 1.5% quarter-over-quarter to $3.34B.

Based on Altrinsic Global Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.